One shot of methadone during surgery could slash opioid prescriptions

NCT ID NCT06536517

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving a single dose of methadone during laparoscopic or robotic hysterectomy can reduce the need for opioid painkillers after surgery. About 100 women with non-cancerous fibroids will be randomly assigned to receive either methadone or standard short-acting opioids during the procedure. The goal is to see if this approach lowers total opioid use in the first week after surgery, helping to prevent overprescription and potential abuse.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Methadone
What this could lead to
If it works, this could point toward a way to manage post-surgery pain with fewer opioid pills, lowering the risk of addiction.
What could go wrong
This is a small, early-phase trial (100 people) testing a single dose. Methadone itself is an opioid, so it may not reduce overall opioid use or could cause side effects like nausea or drowsiness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROID UTERUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Johns Hopkins Bayview Medical Center

    RECRUITING

    Baltimore, Maryland, 21224, United States

  • The Johns Hopkins Hospital

    RECRUITING

    Baltimore, Maryland, 21287, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.